Source recordFED

PRENTKI, Marc

Federal grants & contributions· Canadian Institutes of Health Research· FY2013· $382,479· QC

Description

Metabolic deceleration as a mechanism for the anti-diabetic effects of metformin and berberine

Amendment chain · 1 entry

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.

$382,479$0Original · 2013-01-01 (start date) · total $382,479
  • #02013-01-01$382,479
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2013-01-01(start date)$382,479—Metabolic deceleration as a mechanism for the anti-diabetic effects of metformin and berberine

Related records · 3

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (exact legal name match; no business number on file)

RefDepartment · programCurrent valueFY
236-2012-2013-Q4-00847Canadian Institutes of Health Research | Instituts de recherche en santé du Canada$1,400,000FY2013
236-2011-2012-Q1-00409Canadian Institutes of Health Research | Instituts de recherche en santé du Canada$157,925FY2012
236-2011-2012-Q1-00656Canadian Institutes of Health Research | Instituts de recherche en santé du Canada$747,275FY2012

Cite as: Glassbox record view · Federal grants & contributions · 236-2012-2013-Q4-00783 · retrieved 2026-11-13.